Summary & Overview
CPT 11310: Shaving of Single Epidermal or Dermal Lesion ≤0.5 cm (Face/Mucosa)
CPT code 11310 covers shaving of a single epidermal or dermal lesion 0.5 cm or less in diameter located on cosmetically sensitive areas such as the face, ears, eyelids, nose, lips, or mucous membranes. This code captures a common minor dermatologic destructive procedure with national relevance due to its frequency in outpatient dermatology and primary care settings and its implications for coding accuracy, payment adjudication, and clinical documentation. Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical scope and sites of service, typical payer coverage considerations, common modifiers used in practice, and related coding contexts. The publication outlines benchmarks and reimbursement context where available, highlights coding and documentation elements that affect claims processing, and summarizes clinical scenarios that commonly map to this code. Data not available in the input is noted where applicable. This resource is intended to help coding, billing, and clinical staff understand the purpose and proper use of CPT code 11310 in national practice settings.
Billing Code Overview
CPT code 11310 describes the shaving of a single epidermal or dermal lesion measuring 0.5 cm or less in diameter from the face, ears, eyelids, nose, lips, or mucous membranes. This procedure is a minor skin lesion removal technique performed by a qualified provider.
Service type: Destructive/Excisional Dermatologic Procedure (lesion shaving)
Typical site of service: Outpatient clinic or office-based dermatology or surgical setting, including procedures performed on the face, ears, eyelids, nose, lips, or mucous membranes.
Clinical & Coding Specifications
Clinical Context
A 54-year-old patient presents to an outpatient dermatology clinic with a solitary, raised pigmented papule on the lateral nose measuring 0.4 cm in greatest diameter. The lesion is clinically suspected to be a benign epidermal lesion (e.g., intradermal nevus or seborrheic keratosis) and the clinician elects to perform a shave biopsy with a blade to remove the visible portion of the lesion for both therapeutic and diagnostic purposes. Local anesthesia (infiltration of lidocaine with epinephrine) is administered. The procedure is performed in a minor procedure room; the specimen is labeled and sent to pathology for histologic evaluation. The visit includes pre-procedure evaluation, consent, the shaving procedure of a single lesion 0.5 cm or less on the nose, and brief post-procedure wound care instructions. Typical documentation includes lesion location, size, method (shave), anesthesia, specimen handling, estimated blood loss, and follow-up plan. Payors commonly involved include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the same day as the procedure | Use when an evaluation and management visit is separately documented and medically necessary in addition to the shave procedure. |